Companies/Enorama Pharma AB
Follow
Enorama Pharma AB
Nasdaq First North Sweden (Sweden)
Enorama Pharma AB is a pharmaceutical company that focuses on consumer-friendly medicated chewing gum containing generic substances. It provides medicated gums containing generic pharmaceutical substances, developed through its ChewMed technology platform.
Sector:
HEALTH CARE
>
Drug Manufacturers - Specialty & Generic
Current instruments
Type
Ticker
ISIN
SHARE
ERMA
SE0008216329
Nasdaq First North Sweden Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ERMA
SE0008216329
Nasdaq First North Sweden
Sweden (SE)
Details of share in Enorama Pharma AB with ticker ERMA
Status
Active
Order book id
—
Amount of instruments
5 531 481
Par value
0.1600
Market cap
—
Currency
SEK
Segment
First North
First trading date
10 Jun 2016
Terms
—
Type
Price
Pre-money valuation
Time
IPO
13.00 SEK
47.84M SEK
13 Apr - 29 Apr 2016
IPO in Enorama Pharma AB
Market
Nasdaq First North Sweden
Subscription period
13 Apr - 29 Apr 2016
Subscription price
Price per share
13.00 SEK
Target to raise
23 100 000 SEK
Types
Pre-money valuation
47 840 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
First trading date
10 Jun 2016
Issue terms
Without preferential rights.
Documents
Memorandum/prospectus document
Subscription document
Type
Price
Pre-money valuation
Time
New issue
52.00 SEK
250.5M SEK
01 Nov - 16 Nov 2018
Share issue in Enorama Pharma AB
Market
Nasdaq First North Sweden
Subscription period
01 Nov - 16 Nov 2018
Subscription price
52.00 SEK
Price per share
52.00 SEK
Target to raise
25 047 000 SEK
Types
Share issue
Pre-money valuation
250 500 000 SEK
Subscription block size
Minimum subscription
Record date
30 Oct 2018
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 1:10. Each existing share entitles one (1) subscription right and ten (10) subscription rights entitle to subscribe for one (1) new share.
Documents
Memorandum/prospectus document
Subscription document
Type
Price
Pre-money valuation
Time
New issue
64.40 SEK
341.23M SEK
13 Aug 2019
Share issue in Enorama Pharma AB
Market
Nasdaq First North Sweden
Subscription date
13 Aug 2019
Subscription price
Price per share
64.40 SEK
Target to raise
15 000 000 SEK
Types
Share issue
Pre-money valuation
341 227 393 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed to a few investors.
Comments for offer & related information
Gerhard Dal: 46 000 shares; 2,962,400.00 SEK
Fårö Capital AB: 46 000 shares; 2,962,400.00 SEK
Strategic Wisdom Nordic AB: shares 25 600; 1 648 640.00 SEK
Tommy Ure: shares 22 000; 1 416 800.00 SEK
Johan Stein: shares 20 000; 1 288 000.00 SEK
MW Asset Management: shares 15 527; 999 938.80 SEK
Toni Reftman: shares 15 527; 999 938.80 SEK
Lars-Uno Månsson: shares 7 700; 495 880.00 SEK
Hans Berglund: shares 7 700; 495 880.00 SEK
Jens Miöen: shares 7 700; 495 880.00 SEK
John Andersson Moll: shares 7 700; 495 880.00 SEK
Per Nilsson: shares 7 700; 495 880.00 SEK
Entcap in Gothenburg AB: shares 3 765; 242 466.00 SEK
People
Number of Employees
5 people
Mats-Olle Rönngard
CEO
Anders Ermén
Chairman of the board
Anders Ermén
Board member
Anders Jungbeck
Board member
Mats-Olle Rönngard
Board member
Mats Otto Persson
Board member
Tomas Jörgen Eriksson
Board member
Company Details
Sector
HEALTH CARE
Website
Address
C/O Roccia
Zip code
211 34
City/district
Malmö
Country
Sweden (SE)
Phones
Email
info@enorama.se
Registration number
556716-5591
LEI code
5493008ICNN7HHKZWL40
First trade date
10 Jun 2016
Registration date
28 Nov 2006
Short name
Enorama Pharma

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More